INVO Fertility, Inc. (IVF)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $3.10M
Last updated: Nov 17, 2026 at 11:00 AM ET
INVO Fertility, Inc. (IVF) Financials: Revenue, Profit and Cash Flow
INVO Fertility reported revenue of $6.84M for the fiscal year ended Dec 31, 2025, up 4.7% from the year before. That year, net income was -$23.32M with a net margin of -340.9%, operating cash flow was -$7.01M and free cash flow was -$7.06M. The quarter ended Jun 30, 2026 had revenue of $2.18M and net income of $888.74K.
Revenue and Margins
The operating margin was -85.4% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $50.90K, a compound annual rate of 72.4%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $6.84M | +4.7% | 37.0% | -85.4% | -340.9% |
| Dec 2024 | $6.53M | +116.3% | 44.0% | -124.4% | -139.3% |
| Dec 2023 | $3.02M | +267.4% | 36.0% | -224.0% | -266.0% |
| Dec 2022 | $822.20K | -80.2% | -3.5% | -1292.5% | -1324.8% |
| Dec 2021 | $4.16M | +301.1% | 96.5% | -125.4% | -160.0% |
| Dec 2020 | $1.04M | -29.9% | 91.4% | -531.7% | -804.7% |
| Dec 2019 | $1.48M | +199.4% | 90.6% | -120.8% | -146.4% |
| Dec 2018 | $494.38K | +75.2% | 81.7% | -532.8% | -622.2% |
| Dec 2017 | $282.14K | +454.3% | 81.6% | -227.0% | -248.9% |
| Dec 2016 | $50.90K | N/A | 70.3% | -4146.1% | -4173.3% |
Income Statement
In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Jun 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.84M | $6.53M | $3.02M | $822.20K | $4.16M | $1.04M | $1.48M | $494.38K | $282.14K | $50.90K |
| Cost of revenue | $4.31M | $3.66M | $1.93M | $850.77K | $145.05K | $88.76K | $139.67K | $90.37K | $51.95K | $15.09K |
| Gross profit | $2.53M | $2.87M | $1.09M | -$28.57K | $4.02M | $948.53K | $1.34M | $404.01K | $230.19K | $35.81K |
| Research and development | $0 | $489.66K | $165.94K | $544.04K | $216.43K | $398.43K | $0 | $0 | $0 | $0 |
| Operating income | -$5.84M | -$8.13M | -$6.77M | -$10.63M | -$5.22M | -$5.51M | -$1.79M | -$2.63M | -$640.42K | -$2.11M |
| Net income | -$23.32M | -$9.10M | -$8.03M | -$10.89M | -$6.65M | -$8.35M | -$2.17M | -$3.08M | -$702.16K | -$2.12M |
| EBITDA | -$3.51M | -$7.14M | N/A | N/A | N/A | -$5.48M | -$1.76M | -$2.63M | N/A | -$2.11M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.18M | $2.02M | $1.58M | $1.76M | $1.86M | $1.64M | $1.69M | $1.43M | $1.84M | $1.58M | $1.38M | $974.89K |
| Gross profit | $617.10K | $727.83K | $536.86K | $629.35K | $770.05K | $592.26K | $728.55K | $444.69K | $974.95K | $726.05K | $495.00K | $393.93K |
| Operating income | -$1.29M | -$1.59M | -$1.41M | -$1.64M | -$1.59M | -$2.46M | -$3.98M | -$1.30M | -$1.90M | -$946.37K | -$1.51M | -$886.29K |
| Net income | $888.74K | -$5.54M | $2.01M | -$2.64M | -$5.28M | -$17.40M | -$3.62M | -$1.63M | -$2.25M | -$1.60M | -$1.99M | -$1.25M |
Balance Sheet
As of Dec 2025, total debt of $2.23M exceeded cash and equivalents by $150.53K.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $20.22M | $46.45M | $18.51M | $3.71M | $10.47M | $10.95M | $1.80M | $777.35K | $266.41K | $286.23K |
| Current assets | $2.76M | $1.32M | $1.26M | $621.09K | $6.31M | $10.54M | $1.54M | $731.11K | $234.38K | $251.39K |
| Cash and equivalents | $2.08M | $741.40K | $232.42K | $90.14K | $5.68M | $10.10M | $1.24M | $212.24K | $25.76K | $152.40K |
| Total liabilities | $13.00M | $33.70M | $17.61M | $4.69M | $3.16M | $5.20M | $5.51M | $3.50M | $5.26M | $4.90M |
| Short-term debt | $1.48M | $6.58M | $1.69M | $922.83K | $221.99K | $716.39K | $21.36K | $395.59K | $210.89K | $220.89K |
| Long-term debt | $744.73K | $1.13M | $1.25M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shareholder equity | $7.22M | $12.75M | $892.83K | -$977.61K | $7.31M | $5.74M | -$3.71M | -$2.72M | -$4.99M | -$4.62M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $25.83M | $24.66M | $20.22M | $18.83M | $19.32M | $31.74M | $46.45M | $17.02M | $18.03M | $18.32M | $18.51M | $19.48M |
| Total liabilities | $9.34M | $9.63M | $13.00M | $12.98M | $16.69M | $28.41M | $33.70M | $17.04M | $16.67M | $18.31M | $17.61M | $19.10M |
| Cash and equivalents | $3.73M | $4.90M | $2.08M | $355.89K | $549.18K | $840.41K | $741.40K | $471.59K | $942.93K | $475.13K | $232.42K | $1.06M |
| Shareholder equity | $16.49M | $15.02M | $7.22M | $5.85M | $2.63M | $3.34M | $12.75M | -$23.32K | $1.36M | $10.15K | $892.83K | $372.80K |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$7.01M | -$2.97M | -$4.76M | -$6.60M | -$6.03M | -$4.78M | $1.37M | -$652.97K | -$181.27K | -$323.90K |
| Capital expenditures | $43.41K | $183.70K | $444.73K | $12.73K | $454.65K | $88.93K | $64.84K | $19.40K | $0 | $15.70K |
| Free cash flow | -$7.06M | -$3.16M | -$5.20M | -$6.62M | -$6.48M | -$4.86M | $1.31M | -$672.37K | -$181.27K | -$339.60K |
| Investing cash flow | -$2.75M | $363.89K | -$2.49M | -$81.22K | -$2.15M | -$187.25K | -$114.71K | -$19.40K | N/A | -$15.70K |
| Financing cash flow | $11.10M | $3.12M | $7.39M | $1.09M | $3.77M | $13.82M | -$229.47K | $858.86K | $54.63K | N/A |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$1.10M | -$1.92M | $25.21K | -$1.78M | -$1.72M | -$3.55M | -$617.38K | -$640.81K | -$1.46M | -$260.56K | -$714.88K | -$1.25M |
| Capital expenditures | $190.43K | $210.00K | $11.82K | $8.06K | $8.88K | $14.65K | $78.87K | $3 | $55.13K | $49.70K | $75.00K | $108.22K |
| Free cash flow | -$1.29M | -$2.13M | $13.38K | -$1.78M | -$1.73M | -$3.56M | -$696.25K | -$640.81K | -$1.51M | -$310.25K | -$789.88K | -$1.36M |
Frequently Asked Questions About IVF
What is INVO Fertility's annual revenue?
INVO Fertility reported revenue of $6.84M for the fiscal year ended Dec 31, 2025.
How fast is INVO Fertility's revenue growing?
Revenue was up 4.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 102.6%.
Is INVO Fertility profitable?
No. INVO Fertility reported net income of -$23.32M for the fiscal year ended Dec 31, 2025, with a net margin of -340.9%.
How much free cash flow does IVF generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$7.01M minus capital expenditures of $43.41K produced free cash flow of -$7.06M.
How much debt does INVO Fertility have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $744.73K, short-term debt of $1.48M and cash and equivalents of $2.08M.
IVF pages: Overview, Earnings, Forecast, Financials, Competitors